Background: While programmed death-ligand 1 (PD-L1)-targeted immunotherapy represents an advancement in non-small cell lung cancer (NSCLC), patient outcomes remain suboptimal. Aberrant activation of ...

Thank you for signing up! Did you know with a Digital Subscription to Belfast News Letter, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ...

This is an official implementation in PyTorch of PTH-Net. Our paper is available at https://ieeexplore.ieee.org/abstract/document/10770138 The code is modified from ...

This repository hosts multilspy, a library developed as part of research conducted for NeruIPS 2023 paper titled "Monitor-Guided Decoding of Code LMs with Static Analysis of Repository Context" ...

Google Cloud is moving forward with plans to launch its own layer-1 (L1) blockchain, positioning the network as neutral infrastructure for global finance at a time when fintech competitors are ...

The treatment of tumors remains one of the most challenging issues in modern medicine. For a long time, surgical intervention and radiochemotherapy were the primary methods employed to combat tumors; ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Therapeutic inhibition of programmed cell ...